A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, July 9, 2025 (HealthDay News) — A common virus once thought harmless to ...

In my sixth year of Parkinson's, cognitive changes leave me wondering how much of this decline is due to the disease and how ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...

Parkinsons disease and similar disorders are movement disorders characterised by various nonmotor issues The end-stage poses multifaceted challenges across medical emotional daily-life and caregiver d ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.